Regulation of TGF-β1 gene transcription in human prostate cancer cells by nitric oxide

Prostate

Volumn 67, Issue 16, 2007, Pages 1825-1833

  Wang, Daren ^a   Lu, Shan ^b   Dong, Zhongyun ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Nitric oxide; Prostate cancer cells; TGF 1

Indexed keywords

ALPHA AMINO ACID; AMIDE; ARGININE DERIVATIVE; HEMOGLOBIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; OXIDE; S NITROSOGLUTATHIONE; TRANSFORMING GROWTH FACTOR BETA1; (+ ) E 4 METHYL 2 ((E) HYDROXYLAMINO) 5 NITRO 6 METHOXY 3 HEXANAMIDE; (+-)-E-4-METHYL-2-((E)-HYDROXYLAMINO)-5-NITRO-6-METHOXY-3-HEXANAMIDE; HYDROXYLAMINE; NITRIC OXIDE DONOR; SCAVENGER; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL STRAIN LNCAP; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; MALE; METABOLISM; PROSTATE TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROXYLAMINES; MALE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE II; NITROPRUSSIDE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; S-NITROSO-N-ACETYLPENICILLAMINE; S-NITROSOGLUTATHIONE; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 36849016455     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20669     Document Type: Article

References (44)

1. Massague J, Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 2000;19(8):1745-1754.
2. Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001;29(2):117-129.
3. Lee C, Sintich SM, Mathews EP, Shah AH, Kundu SD, Perry KT, Cho JS, Ilio KY, Cronauer MV, Janulis L, Sensibar JA. Transforming growth factor-beta in benign and malignant prostate. Prostate 1999;39(4):285-290.
4. Ilio KY, Sensibar JA, Lee C. Effect of TGF-beta1, TGF-alpha, and EGF on cell proliferation and cell death in rat ventral prostatic epithelial cells in culture. J Androl 1995;16(6):482-490.
5. Wikstrom P, Damber JE, Bergh A. Role of transforming growth factor-beta1 in prostate cancer. Microsc Res Tech 2001;52(4):411-419.
6. Perry KT, Anthony CT, Case T, Steiner MS. Transforming growth factor beta as a clinical biomarker for prostate cancer. Urology 1997;49(1):151-155.
7. Steiner MS, Zhou ZZ, Tonb DC, Barrack ER. Expression of transforming growth factor-beta 1 in prostate cancer. Endocrinology 1994;135(5):2240-2247.
8. Stearns ME, Garcia FU, Fudge K, Rhim J, Wang M. Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice. Clin Cancer Res 1999;5(3):711-720.
9. Matthews E, Yang T, Janulis L, Goodwin S, Kundu SD, Karpus WJ, Lee C. Down-regulation of TGF-beta1 production restores immunogenicity in prostate cancer cells. Br J Cancer 2000;83(4): 519-525.
10. Fleisch MC, Maxwell CA, Barcellos-Hoff MH. The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs. Endocr Relat Cancer 2006; 13(2):379-400.
11. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269(19):13725-13728.
12. Zhou J, Brune B. NO and transcriptional regulation: From signaling to death. Toxicol 2005;208(2):223-233.
13. Olson MV, Lee J, Zhang F, Wang A, Dong Z. Inducible nitric oxide synthase activity is essential for inhibition of prostatic tumor growth by interferon-beta gene therapy. Cancer Gene Ther 2006;13(7):676-685.
14. Zhang F, Lu W, Dong Z. Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice. Clin Cancer Res 2002;8(9):2942-2951.
15. Kowaluk EA, Seth P, Fung HL. Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J Pharm Exp Ther 1992;262(3):916-922.
16. Nishio E, Fukushima K, Shiozaki M, Watanabe Y. Nitric oxide donor SNAP induces apoptosis in smooth muscle cells through cGMP-independent mechanism. Biochem Biophys Res Comm 1996;221(1):163-168.
17. Radomski MW, Rees DD, Dutra A, Moncada S. S-nitrosoglutathione inhibits platelet activation in vitro and in vivo. Br J Pharm 1992;107(3):745-749.
18. Percival MD, Ouellet M, Campagnolo C, Claveau D, Li C. Inhibition of cathepsin K by nitric oxide donors: Evidence for the formation of mixed disulfides and a sulfenic acid. Biochemistry 1999;38(41):13574-13583.
19. Akaike T, Yoshida M, Miyamoto Y, Sato K, Kohno M, Sasamoto K, Miyazaki K, Ueda S, Maeda H. Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/NO through a radical reaction. Biochemistry 1993; 32(3):827-832.
20. Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 1989;86(22):9030-9033.
21. Yoshimura T, Yokoyama H, Fujii S, Takayama F, Oikawa K, Kamada H. In vivo EPR detection and imaging of endogenous nitric oxide in lipopolysaccharide- treated mice. Nat Biotechnol 1996;14(8):992-994.
22. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP. LNCaP model of human prostatic carcinoma. Cancer Res 1983;43(4):1809-1818.
23. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF. Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 1978;21(3):274-281.
24. Lu S, Dong Z. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells. Prostate 2006; 66:996-1004.
25. Simon P. Q-Gene: Processing quantitative real-time RT-PCR data. Bioinformatics 2003;19(11):1439-1440.
26. Dong Z, Staroselsky AH, Qi X, Xie K, Fidler IJ. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res 1994;54(3):789-793.
27. Aaltoma SH, Lipponen PK, Kosma VM. Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer. Anticancer Res 2001;21(4B):3101-3106.
28. Wang J, Torbenson M, Wang Q, Ro JY, Becich M. Expression of inducible nitric oxide synthase in paired neoplastic and non-neoplastic primary prostate cell cultures and prostatectomy specimen. Urol Oncol 2003;21(2):117-122.
29. Geiser AG, Busam KJ, Kim SJ, Lafyatis R, O'Reilly MA, Webbink R, Roberts AB, Sporn MB. Regulation of the transforming growth factor-beta 1 and -beta 3 promoters by transcription factor Sp1. Gene 1993;129(2):223-228.
30. Mitsumoto M, Mitsumoto A, Demple B. Nitric oxide-mediated upregulation of the TGF-beta-inducible early response gene-1 (TIEG1) in human fibroblasts by mRNA stabilization independent of TGF-beta. Free Radical Biol Med 2003;34(12):1607-1613.
31. Levonen AL, Patel RP, Brookes P, Go YM, Jo H, Parthasarathy S, Anderson PG, Darley-Usmar VM. Mechanisms of cell signaling by nitric oxide and peroxynitrite: From mitochondria to MAP kinases. Antioxid Redox Signal 2001;3(2):215-229.
32. Cary SP, Winger JA, Derbyshire ER, Marietta MA. Nitric oxide signaling: No longer simply on or off. Trends Biochem Sci 2006; 31(4):231-239.
33. Yang T, Zhang A, Pasumarthy A, Zhang L, Warnock Z, Schnermann JB. Nitric oxide stimulates COX-2 expression in cultured collecting duct cells through MAP kinases and superoxide but not cGMP. Am J Physiol 2006;291(4):F891-F895.
34. Ridnour LA, Isenberg JS, Espey MG, Thomas DD, Roberts DD, Wink DA. Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc Natl Acad Sci USA 2005;102(37):13147-13152.
35. Kuwabara M, Kakinuma Y, Ando M, Katare RG, Yamasaki F, Doi Y, Sato T. Nitric oxide stimulates vascular endothelial growth factor production in cardiomyocytes involved in angiogenesis. J Physiol Sci 2006;56(1):95-101.
36. Park SW, Lee SG, Song SH, Heo DS, Park BJ, Lee DW, Kim KH, Sung MW. The effect of nitric oxide on cyclooxygenase-2 (COX-2) overexpression in head and neck cancer cell lines. Int J Cancer 2003;107(5):729-738.
37. Roy A, Fung YK, Liu X, Pahan K. Up-regulation of microglial CD11b expression by nitric oxide. J Biol Chem 2006;281(21): 14971-14980.
38. Kim Y, Ratziu V, Choi SG, Lalazar A, Theiss G, Dang Q, Kim SJ, Friedman SL. Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. J Biol Chem 1998; 273(50):33750-33758.
39. Sellak H, Yang X, Cao X, Cornwell T, Soff GA, Lincoln T. Sp1 transcription, factor as a molecular target for nitric oxide- and cyclic nucleotide-mediated suppression of cGMP-dependent protein kinase-ialpha expression in vascular smooth muscle cells. Circ Res 2002;90(4):405-412.
40. Wikstrom P, Lindh G, Bergh A, Damber JE. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines. Urol Res 1999;27(3):185-193.
41. Dumont N, Arteaga CL. Targeting the TGF beta signaling network in human neoplasia. Cancer Cell 2003;3(6):531-536.
42. Wang Z, Cook T, Alber S, Liu K, Kovesdi I, Watkins SK, Vodovotz Y, Billiar TR, Blumberg D. Adenoviral gene transfer of the human inducible nitric oxide synthase gene enhances the radiation response of human colorectal cancer associated with alterations in tumor vascularity. Cancer Res 2004;64(4):1386-1395.
43. Cook T, Wang Z, Alber S, Liu K, Watkins SC, Vodovotz Y, Billiar TR, Blumberg D. Nitric oxide and ionizing radiation synergistically promote apoptosis and growth inhibition of cancer by activating p53. Cancer Res 2004;64(21):8015-8021.
44. Frederiksen LJ, Sullivan R, Maxwell LR, Macdonald-Goodfellow SK, Adams MA, Bennett BM, Siemens DR, Graham CH. Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling. Clin Cancer Res 2007;13(7):2199-2206.